courtlistener_docket
2 records
Andree v. Perrigo Company
2026-05-29
Federal docket 1:26-cv-01724 (miwd); matched party 'Perrigo Company'
View Source
Ballard v. Perrigo Company
2026-05-27
Federal docket 1:26-cv-01710 (miwd); matched party 'Perrigo Company'
View Source
epa_echo
1 records
fda
106 records
FDA Drug Recall: No Drip Nasal Spray, Oxymetazoline HCl 0.05% Nasal Decongestant, 1 FL Oz (30 mL)
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Acetaminophen Child Bubble Gum Flavored Oral Suspension (160 mg/5 ml), 4 FL OZ (
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Severe Congestion Nasal Spray, No Drip Plus Menthol, Oxymetazoline HCl 0.05%, 1
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Maximum Strength No Drip Nasal Spray, Oxymetazoline HCl 0.05% Nasal Decongestant
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Children's Pain & Fever Bubblegum Flavored Acetaminophen Suspension (160mg/5ml)
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Severe Congestion Nasal Spray, No Drip Plus Menthol, Oxymetazoline HCl 0.05%, 1
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Infant's Grape Flavored Acetaminophen Oral Suspension (160mg/5ml), 2 FL OZ (59 m
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Acetaminophen Child Dye Free Cherry Flavor Oral Suspension (160mg/5ml), 4 FL OZ
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Maximum Strength No Drip Nasal Spray, Oxymetazoline HCl 0.05% Nasal Decongestant
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Acetaminophen Child Strawberry Oral Suspension (160 mg/5 ml), 4 FL OZ (118 mL) p
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Severe Congestion No Drip Nasal Spray Plus Menthol, Oxymetazoline HCl 0.05%, 1 F
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Maximum Strength No Drip Nasal Spray, Oxymetazoline HCl 0.05% Nasal Decongestant
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Acetaminophen Child Strawberry Oral Suspension (160 mg/5 ml), 4 FL OZ (118 mL) p
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Severe Congestion Nasal Spray, No Drip Plus Menthol, Oxymetazoline HCl 0.05%, 1
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Maximum Strength Plus Menthol No Drip Nasal Spray, Oxymetazoline HCl 0.05% Nasal
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: No Drip Nasal Spray, Oxymetazoline HCl 0.05% Nasal Decongestant, 1 FL Oz (30 mL)
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Acetaminophen Child Bubble Gum Flavored Oral Suspension (160 mg/5 ml), 4 FL OZ (
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Severe Congestion Nasal Spray, No Drip Plus Menthol, Oxymetazoline HCl 0.05%, 1
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Acetaminophen Child Dye Free Cherry Flavor Oral Suspension (160mg/5ml), 4 FL OZ
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Acetaminophen Infant Dye Free Grape Oral Suspension (160mg/5ml), 2 FL OZ (59 mL)
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Maxiumum Strength No Drip Nasal Spray, Oxymetazoline HCl 0.05% Nasal Decongestan
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Infant's Grape Flavored Acetaminophen Oral Suspension (160mg/5ml), 2 FL OZ (59 m
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: No Drip Nasal Decongestant, Oxymetazoline HCl 0.05%, 1 FL Oz (30 mL) per bottle,
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Acetaminophen Child Dye Free Cherry Flavor Oral Suspension (160mg/5ml), 4 FL OZ
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Children's Grape Flavored Acetaminophen Oral Suspension (160mg/5ml), 4 FL OZ (11
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Maximum Strength No Drip Nasal Spray, Oxymetazoline HCl 0.05% Nasal Decongestant
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Sinus Severe, Oxymetazoline HCl 0.05% Nasal Decongestant with Menthol, 1 FL Oz (
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Acetaminophen Infant Dye Free Grape Oral Suspension (160mg/5ml), 2 FL OZ (59 mL)
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Severe Congestion Nasal Spray, No Drip Plus Menthol, Oxymetazoline HCl 0.05% Nas
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Maximum Strength No Drip Nasal Spray, Oxymetazoline HCl 0.05% Nasal Decongestant
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Soothing 12 Hour Nasal Decongestant Spray No Drip, Oxymetazoline HCl 0.05%, 1 FL
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Children's Grape Flavored Acetaminophen Oral Suspension (160mg/5ml), 4 FL OZ (11
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Children's Grape Flavored Acetaminophen Oral Suspension (160mg/5ml), 4 FL OZ (11
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Maximum Strength No Drip Nasal Spray, Oxymetazoline HCl 0.05% Nasal Decongestant
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Severe Congestion Nasal Spray, No Drip Plus Menthol, Oxymetazoline HCl 0.05%, 1
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: No Drip Nasal Mist, Oxymetazoline HCl 0.05% Nasal decongestant, 1 FL Oz (30 mL)
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: No Drip Nasal Spray, Oxymetazoline HCl 0.05% Nasal Decongestant, 1 FL Oz (30 mL)
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Acetaminophen Infant Dye Free Grape Oral Suspension (160mg/5ml), 2 FL OZ (59 mL)
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Acetaminophen Child Strawberry Oral Suspension (160 mg/5 ml), 4 FL OZ (118 mL) p
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Acetaminophen Child Dye Free Cherry Flavor Oral Suspension (160mg/5ml), 4 FL OZ
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Children's Grape Flavored Acetaminophen Oral Suspension (160mg/5ml), 4 FL OZ (11
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Acetaminophen Child Bubble Gum Flavored Oral Suspension (160 mg/5 ml), two 4 FL
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Severe Congestion Nasal Spray, No Drip Plus Menthol, Oxymetazoline HCl 0.05%, 1
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Maximum Strength Nasal Spray, Oxymetazoline HCl 0.05% Nasal Decongestant with Me
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Acetaminophen Infant Dye Free Grape Oral Suspension (160mg/5ml), 2 FL OZ (59 mL)
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Severe Congestion Nasal Spray, No Drip Plus Menthol, Oxymetazoline HCl 0.05%, 1
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Maximum Strength Nasal Spray, Oxymetazoline HCl 0.05% Nasal Decongestant with Me
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Acetaminophen Oral Suspension Grape Flavor, 160 mg per 5 mL, 16 fl oz (473 mL) p
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Nasal Spray Decongestant, No Drip, Oxymetazoline HCl 0.05%, 1 FL Oz (30 mL) per
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Children's Cherry Flavored Acetaminophen Oral Suspension (160mg/5ml), 4 FL OZ (1
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: Children's Pain & Fever Acetaminophen, 160 mg per 5 mL Oral Suspension combo pac
2022-03-02
Class II — CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
View Source
FDA Drug Recall: GoodSense Aller.Ease, Fexofenadine hydrochloride 12 HR, 60 mg tablets, 24 count
2022-01-12
Class II — Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
View Source
FDA Drug Recall: CVS Allergy Relief, Fexofenadine Hydrochloride Tablets, 60 mg Antihistamine, 12
2022-01-12
Class II — Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
View Source
FDA Drug Recall: Meijer allergy relief, Fexofenadine Hydrochloride tablets, 24HR, 1800mg Antihist
2022-01-12
Class II — Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
View Source
FDA Drug Recall: Perrigo Fexofenadine Hydrochloride tablets, 12HR, 60mg Antihistamine, 100 count
2022-01-12
Class II — Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
View Source
FDA Drug Recall: Rite Aid ALLERGY RELIEF Fexofenadine Hydrochloride tablets, 12HR, 60mg Antihista
2022-01-12
Class II — Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
View Source
FDA Drug Recall: Kroger Allergy Relief, Fexofenadine Hydrochloride tablets, 12HR, 60mg Antihistam
2022-01-12
Class II — Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
View Source
FDA Drug Recall: amazon basic+care, Allergy Fexofenadine Hydrochloride Tablets, 60 mg/Antihistami
2022-01-12
Class II — Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
View Source
FDA Drug Recall: basic+care, allergy Fexofenadine Hydrochloride Tablets, 180 mg/Antihistamine, 2
2022-01-12
Class II — Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
View Source
FDA Drug Recall: TopCare Allergy Relief, Fexofenadine Hydrochloride tablets, 12HR, 60mg Antihista
2022-01-12
Class II — Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
View Source
FDA Drug Recall: basic+care, allergy Fexofenadine Hydrochloride Tablets, 60 mg/Antihistamine, 12
2022-01-12
Class II — Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
View Source
FDA Drug Recall: Wal-Fex Fexofenadine Hydrochloride tablets, 60mg/antihistamine, 12HR, 24 coun
2022-01-12
Class II — Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
View Source
FDA Drug Recall: Health Mart, Fexofenadine Hydrochloride tablets, 24HR, 180mg . Antihistamine
2022-01-12
Class II — Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
View Source
FDA Drug Recall: TopCare Allergy Relief, Fexofenadine Hydrochloride tablets, 24HR, 180mg Antihist
2022-01-12
Class II — Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
View Source
FDA Drug Recall: up&up allergy relief, Fexofenadine Hydrochloride tablets, 24HR, 180mg/antihistam
2022-01-12
Class II — Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
View Source
FDA Drug Recall: EQUALINE aller-ease fexofenadine hydrochloride tablets, 180 mg, 24 HR, packaged
2022-01-12
Class II — Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
View Source
FDA Drug Recall: H.E.B Allergy Relief, Fexofenadine Hydrochloride tablets, 12HR, 60mg/Antihistami
2022-01-12
Class II — Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
View Source
FDA Drug Recall: H.E.B Allergy Relief, Fexofenadine Hydrochloride tablets, 24HR, 180mg/Antihistam
2022-01-12
Class II — Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
View Source
FDA Drug Recall: CAREONE Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg Antihistamine
2022-01-12
Class II — Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
View Source
FDA Drug Recall: amazon, Allergy Fexofenadine Hydrochloride Tablets, 180 mg/Antihistamine, 24 H
2022-01-12
Class II — Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
View Source
FDA Drug Recall: Wal-Fex Fexofenadine Hydrochloride tablets, 180mg/antihistamine, 24HR, package
2022-01-12
Class II — Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
View Source
FDA Drug Recall: DG/health Aller.Ease, Fexofenadine Hydrochloride Tablets, 180 mg/Antihistamine,
2022-01-12
Class II — Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
View Source
FDA Drug Recall: Health Mart, Fexofenadine Hydrochloride tablets, 12HR, 60mg . Antihistamine
2022-01-12
Class II — Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
View Source
FDA Drug Recall: allergyrelief, Fexofenadine Hydrochloride tablets, 24HR, 1800mg Antihistamine, p
2022-01-12
Class II — Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
View Source
FDA Drug Recall: Rite Aid ALLERGY RELIEF Fexofenadine Hydrochloride tablets, 24HR, 180mg Antihist
2022-01-12
Class II — Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
View Source
FDA Drug Recall: KIRKLAND ALLER-FEX, Fexofenadine Hydrochloride Tablets, 180 mg/Antihistamine, 2
2022-01-12
Class II — Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
View Source
FDA Drug Recall: GoodSense Aller.Ease, Fexofenadine hydrochloride 24 HR, 180 mg tablets, 30 count
2022-01-12
Class II — Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
View Source
FDA Drug Recall: Perrigo Fexofenadine Hydrochloride tablets, 24HR, 180mg Antihistamine, 100 coun
2022-01-12
Class II — Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
View Source
FDA Drug Recall: berkley jensen, ALLERGY RELIEF, Fexofenadine Hydrochloride Tablets, 180 mg Antih
2022-01-12
Class II — Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
View Source
FDA Drug Recall: CVS Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg Antihistamine, 24
2022-01-12
Class II — Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
View Source
FDA Drug Recall: MAJOR, Fexofenadine Hydrochloride tablets, 12HR, 60mg Antihistamine, 100 count b
2022-01-12
Class II — Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
View Source
FDA Drug Recall: Albuterol Sulfate Inhalation Aerosol, 90 mcg per actuation, 200 metered inhalati
2020-09-30
Class II — Defective Delivery System: Sustained trend of failure to dispense complaints.
View Source
FDA Drug Recall: Regular Strength Acid Reducer, Ranitidine tablets, USP 75 mg, 80 tablets per bot
2020-03-25
Class II — CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
View Source
FDA Drug Recall: Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 50 tablets per bo
2020-03-25
Class II — CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
View Source
FDA Drug Recall: Regular Strength Acid Reducer, Ranitidine tablets, USP 75 mg, 30 tablets per bot
2020-03-25
Class II — CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
View Source
FDA Drug Recall: Maximum Strength Acid Reducer, Cool Mint Ranitidine tablets, USP 150 mg, 95 tabl
2020-03-25
Class II — CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
View Source
FDA Drug Recall: Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 24 tablets per bo
2020-03-25
Class II — CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
View Source
FDA Drug Recall: Regular Strength Acid Reducer, Ranitidine tablets, USP 75 mg, 160 tablets per bo
2020-03-25
Class II — CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
View Source
FDA Drug Recall: Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 90 tablets per bo
2020-03-25
Class II — CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
View Source
FDA Drug Recall: Maximum Strength Acid Reducer, Cool Mint Ranitidine tablets, USP 150 mg, 40 tabl
2020-03-25
Class II — CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
View Source
FDA Drug Recall: Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 200 tablets per b
2020-03-25
Class II — CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
View Source
FDA Drug Recall: Maximum Strength Acid Reducer, Cool Mint Ranitidine tablets, USP 150 mg, 24 tabl
2020-03-25
Class II — CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
View Source
FDA Drug Recall: Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 65 tablets per bo
2020-03-25
Class II — CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
View Source
FDA Drug Recall: Maximum Strength Acid Reducer, Cool Mint Ranitidine tablets, USP 150 mg, 65 tabl
2020-03-25
Class II — CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
View Source
FDA Drug Recall: Regular Strength Acid Reducer, Ranitidine tablets, USP 75 mg, 150 tablets per bo
2020-03-25
Class II — CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
View Source
FDA Drug Recall: Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 95 tablets per bo
2020-03-25
Class II — CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
View Source
FDA Drug Recall: Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 8 tablets. [NDC:
2020-03-25
Class II — CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
View Source
FDA Drug Recall: Maximum Strength Acid Reducer, Cool Mint Ranitidine tablets, USP 150 mg, 90 tabl
2020-03-25
Class II — CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
View Source
FDA Drug Recall: Regular Strength Acid Reducer, Ranitidine tablets, USP 75 mg, 60 tablets per bot
2020-03-25
Class II — CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
View Source
FDA Food Recall: Parent's Choice Advantage Infant Formula Milk-Based Powder with Iron, 35 oz, 922
2019-07-24
Class II — Product may contain metal fragments.
View Source
FDA Food Recall: Simple Truth Organic Banana, Strawberry & Apple Fruit Puree with Nonfat Greek Yo
2019-03-20
Class II — Perrigo Company is initiating a voluntary recall of one production lot of Simple Truth Organic Banana, Strawberry and Apple Fruit Puree with Nonfat Greek Yogurt, LOT L8159, best by 08/06/20...
View Source
FDA Drug Recall: Nystatin, USP Powder for Rx compounding, 50 Million Units, Packaged by Perrigo,
2016-02-10
Class II — Labeling: label error on declared strength.
View Source
FDA Drug Recall: Nystatin, USP Powder for Rx compounding, 150 Million Units, Packaged by Perrigo,
2016-02-10
Class II — Labeling: label error on declared strength.
View Source
FDA Drug Recall: Guaifenesin DM Cherry liquid (guaifenesin 100 mg/5 mL and Dextromethorphan HBr 5
2016-02-03
Class II — Defective Delivery System: Firm recalled Guaifenesin liquid and Guaifenesin DM liquid due incorrect dose markings on the dosing cups.
View Source
FDA Drug Recall: Guaifenesin Grape liquid 100 mg/5 mL, packaged in 4oz. bottles, co-packaged with
2016-02-03
Class II — Defective Delivery System: Firm recalled Guaifenesin liquid and Guaifenesin DM liquid due incorrect dose markings on the dosing cups.
View Source
FDA Drug Recall: Cetirizine HCl 10 mg Tablet, 14 count blister packs, sold over the counter under
2015-12-30
Class III — Failed Impurity/Degradations Specifications; impurity identified as cetirizine monosaccharide ester
View Source
ftc
1 records
ftc_enforcement
3 records
Perrigo Company and Paddock Laboratories, Inc., In the Matter of
2012-06-26
FTC live enforcement action FY2012; matched respondent 'Perrigo Company'
View Source
Perrigo Company and Alpharma Inc., F.T.C.
2006-07-21
FTC live enforcement action FY2006; matched respondent 'Perrigo Company'
View Source
Perrigo Company, In the Matter of
2003-06-23
FTC live enforcement action FY2003; matched respondent 'Perrigo Company, In the Matter of'
View Source
lobbying
6 records
Lobbying Client: PERRIGO COMPANY PLC
Lobbied by ARNOLD & PORTER KAYE SCHOLER LLP — Manufacturer of over-the-counter consumer self-care products, including infant formula.
View Source
Lobbying Client: PERRIGO COMPANY PLC
Lobbied by ARNOLD & PORTER KAYE SCHOLER LLP — Manufacturer of over-the-counter consumer self-care products, including infant formula.
View Source
Lobbying Client: PERRIGO COMPANY
Lobbied by SQUIRE PATTON BOGGS — Client is an American Irish-registered manufacturer of private label OTC pharmaceuticals.
View Source
Lobbying Client: PERRIGO COMPANY PLC
Lobbied by COVINGTON & BURLING LLP — Self-care products
View Source
Lobbying Client: PERRIGO COMPANY PLC
Lobbied by ARNOLD & PORTER KAYE SCHOLER LLP — Manufacturer of over-the-counter consumer self-care products, including infant formula.
View Source
ny_spills
3 records
NY Spill: PERRIGO — solvents
2008-04-10
BRONX, Bronx County | 0.00 Gallons of solvents
NY Spill: PERRIGO — solvents
2008-04-10
BRONX, Bronx County | 0.00 Gallons of solvents
NY Spill: PERRIGO — solvents
2008-04-10
BRONX, Bronx County | 0.00 Gallons of solvents
SEC EDGAR
1 records
Be informed when major changes happen on C.F.A.I. — new data sources, platform updates, critical enforcement alerts
No spam. Only major updates. Unsubscribe anytime.